Charles T Esmon1. 1. Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma, USA. charles-esmon@omrf.ouhsc.edu
Abstract
PURPOSE OF REVIEW: The endothelial cell protein C receptor is known to be critical for the regulation of natural anticoagulant functions and some anti-inflammatory and anti-apoptotic functions of activated protein C. This leads to the prediction that abnormalities in endothelial cell protein C receptor might be associated with altered thrombotic tendencies and hyperinflammatory responses to infectious agents. This review covers the most recent evidence that relatively common genetic and acquired abnormalities of endothelial cell protein C receptor do contribute to pathophysiological disease processes. RECENT FINDINGS: In mice, increases and decreases in endothelial cell protein C receptor expression are shown to modulate the coagulation and inflammatory proceses. Genetic polymorphisms are associated with alterations in protein expression and familial and acquired thrombotic disease. SUMMARY: The emerging clinical evidence of endothelial cell protein C receptor involvement in thrombotic disease suggests that the understanding of endothelial cell protein C receptor genotype and the knowledge of auto-antibodies may aid in diagnosing the risk of thrombotic events in patients.
PURPOSE OF REVIEW: The endothelial cell protein C receptor is known to be critical for the regulation of natural anticoagulant functions and some anti-inflammatory and anti-apoptotic functions of activated protein C. This leads to the prediction that abnormalities in endothelial cell protein C receptor might be associated with altered thrombotic tendencies and hyperinflammatory responses to infectious agents. This review covers the most recent evidence that relatively common genetic and acquired abnormalities of endothelial cell protein C receptor do contribute to pathophysiological disease processes. RECENT FINDINGS: In mice, increases and decreases in endothelial cell protein C receptor expression are shown to modulate the coagulation and inflammatory proceses. Genetic polymorphisms are associated with alterations in protein expression and familial and acquired thrombotic disease. SUMMARY: The emerging clinical evidence of endothelial cell protein C receptor involvement in thrombotic disease suggests that the understanding of endothelial cell protein C receptor genotype and the knowledge of auto-antibodies may aid in diagnosing the risk of thrombotic events in patients.
Authors: David K C Cooper; Burcin Ekser; Christopher Burlak; Mohamed Ezzelarab; Hidetaka Hara; Leela Paris; A Joseph Tector; Carol Phelps; Agnes M Azimzadeh; David Ayares; Simon C Robson; Richard N Pierson Journal: Xenotransplantation Date: 2012 May-Jun Impact factor: 3.907
Authors: B Levy; S Collin; N Sennoun; N Ducrocq; A Kimmoun; P Asfar; P Perez; F Meziani Journal: Intensive Care Med Date: 2010-09-23 Impact factor: 17.440
Authors: Jens E V Petersen; Eveline A M Bouwens; Ibai Tamayo; Louise Turner; Christian W Wang; Monique Stins; Thor G Theander; José Hermida; Laurent O Mosnier; Thomas Lavstsen Journal: Thromb Haemost Date: 2015-07-09 Impact factor: 5.249
Authors: Burcin Ekser; Christopher Burlak; Joshua P Waldman; Andrew J Lutz; Leela L Paris; Massimiliano Veroux; Simon C Robson; Michael A Rees; David Ayares; Bruno Gridelli; A Joseph Tector; David Kc Cooper Journal: Expert Rev Clin Immunol Date: 2012-09 Impact factor: 4.473